The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation

Published:2010-10-27 Issue:2 Volume:4 Page:172-185
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Meylan F,Song Y-J,Fuss I,Villarreal S,Kahle E,Malm I-J,Acharya K,Ramos H L,Lo L,Mentink-Kane M M,Wynn T A,Migone T-S,Strober W,Siegel R M

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi201067.pdf

Reference60 articles.

1. Screaton, G.R. et al. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94, 4615–4619 (1997).

2. Marsters, S.A. et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr. Biol. 6, 1669–1676 (1996).

3. Migone, T.S. et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479–492 (2002).

4. Meylan, F. et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79–89 (2008).

5. Pappu, B.P. et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205, 1049–1062 (2008).

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD;Gut;2024-09-11

2. Progress in research of TNF-like cytokine 1A as a therapeutic target for inflammatory bowel disease;World Chinese Journal of Digestology;2024-06-28

3. Chronic skin damage induces small intestinal damage via IL-13-induced apoptosis;Clinical and Experimental Immunology;2024-06-25

4. TL1A and IL-18 synergy promotes GM-CSF-dependent thymic granulopoiesis in mice;Cellular & Molecular Immunology;2024-06-05

5. TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis;Med;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3